|Bid||0.3023 x N/A|
|Ask||0.3241 x N/A|
|Day's Range||0.3202 - 0.3202|
|52 Week Range||0.2984 - 2.5600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for 17DN.MU
Arcadia Biosciences, Inc.® (NASDAQ: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CFO Pam Haley will be leaving the company and will be replaced by Thomas J. Schaefer, effective January 3, 2023. Schaefer is currently Arcadia's vice president of finance and investor relations. Haley will remain in an advisory role to support the transition.
Arcadia Biosciences ( NASDAQ:RKDA ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.88m (down 21% from...
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?